Europe breast lesion localization methods is expected to reach USD 143.49 million by 2025 from USD 56.05 million in 2017, at a CAGR of 12.6% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors driving the market are technological advancements and rising prevalence of cancer cases in breast localization, the breast lesion localization methods market in the Europe region is leading in U.K.

The key market players for Europe breast lesion localization methods Market are listed below;

C. R. Bard, Inc.
CP Medical, Inc.
Cianna Medical
Cook Group
STERYLAB S.r.l.
SOMATEX Medical Technologies GmbH
Elucent Medical
ARGON MEDICAL
Tsunami S.r.l.
M.D.L. srl
Biomedical Srl


The market is further segmented into;
Type
Biopsy techniques
End-user


The Europe breast lesion localization methods market is segmented on the basis of type, biopsy technique and end users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
The Europe breast lesion localization market is segmented based on type into wire localization, radioisotope localization, magnetic tracers and others. Europe breast lesion localization market is dominated by wire localization with 31.9% market share in 2018, growing at a CAGR of 12.1% in the forecast period. The radioisotope localization is further sub segmented into radioactive seed localization and radio occult lesion localization.
The Europe breast lesion localization market is segmented on the basis of biopsy techniques into fine needle aspiration biopsy, core needle biopsy, surgical biopsy, vacuum-assisted breast biopsy and others. Europe breast lesion localization market is dominated by fine needle aspiration biopsy with 31.9% market share in 2018, growing at a CAGR of 12.6% in the forecast period. The surgical biopsy is further sub segmented into incisional biopsy and excisional biopsy.
The Europe breast lesion localization market is segmented on the basis of end user into diagnostic centers, hospitals, oncology clinics and ambulatory surgical centers. Europe breast lesion localization market is dominated by hospitals with 32.0% market share in 2018, growing at a CAGR of 13.0% in the forecast period.
Based on geography, the Europe breast lesion localization market methods market is segmented into geographical regions, such as,
Germany,
United Kingdom,
France,
Spain,
Italy,
Russia,
Turkey,
Belgium,
Nether lands,
Switzerland,
Rest of Europe

Covered in this report
The report covers the present scenario and the growth prospects of the Europe breast lesion localization market market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.